- Home
- HTLD vs EBS Comparison
HTLD vs EBS Comparison
Compare HTLD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HTLD | EBS |
|---|---|---|
| Founded | 1978 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.1M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | HTLD | EBS |
|---|---|---|
| Price | $9.09 | $12.81 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.25 | ★ $15.00 |
| AVG Volume (30 Days) | 682.2K | ★ 875.6K |
| Earning Date | 01-27-2026 | 10-29-2025 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $868,930,000.00 | $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.73 | $15.21 |
| P/E Ratio | ★ N/A | $9.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $4.02 |
| 52 Week High | $12.19 | $13.41 |
Technical Indicators
Market Signals| Indicator | HTLD | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 67.48 |
| Support Level | $8.92 | $12.06 |
| Resistance Level | $9.52 | $12.28 |
| Average True Range (ATR) | 0.26 | 0.55 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 59.84 | 92.91 |
Price Performance
Historical ComparisonAbout HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.